Celastrol (GMP)

Celastrol (GMP) (Tripterine (GMP) ) is Celastrol (HY-10227) produced by using GMP guidelines. GMP small molecules works appropriately as an auxiliary reagent for cell therapy manufacture. Celastrol (Tripterine; Tripterin) is a proteasome inhibitor which potently and preferentially inhibits the chymotrypsin-like activity of a purified 20S proteasome with IC50 of 2.5 μM. In addition, Celastrol is also an antibiotic with potent antimicrobial activity against standard and clinical methicillin-resistant Staphylococcus aureus (MRSA) strains, inducing oxidative stress and inhibiting DNA synthesis by binding to P5CDH[1][2][3].

Product Specifications

CAS Number

[34157-83-0]

Product Name Alternative

Tripterine (GMP) ; Tripterin (GMP)

UNSPSC

12352211

Target

Antibiotic; Apoptosis; Autophagy; Bacterial; Endogenous Metabolite; Mitophagy; Proteasome

Related Pathways

Anti-infection; Apoptosis; Autophagy; Metabolic Enzyme/Protease

Field of Research

Cancer; Infection; Inflammation/Immunology

Smiles

OC1=C(C2=CC=C3[C@](C)([C@]4(CC[C@]3(C2=CC1=O)C)C)CC[C@@]5(C)CC[C@@](C(O)=O)(C[C@]54[H])C)C

Molecular Formula

C29H38O4

Molecular Weight

450.61

References & Citations

[1]Yang H, et al. Celastrol, a triterpene extracted from the Chinese "Thunder of God Vine, " is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice. Cancer Res. 2006 May 1;66 (9) :4758-65|[2]Guan Y, et al. Celastrol attenuates oxidative stress in the skeletal muscle of diabetic rats by regulating the AMPK-PGC1α-SIRT3 signaling pathway. Int J Mol Med. 2016 May;37 (5) :1229-38.|[3]Yuan Z, et al. Celastrol Combats Methicillin‐Resistant Staphylococcus aureus by Targeting Δ1‐Pyrroline‐5‐Carboxylate Dehydrogenase[J]. Advanced Science, 2023, 10 (25) : 2302459.